KNOT Offshore Partners LP reported strong Q2 2026 results, beating analyst expectations with an EPS of $0.10 versus an estimated loss of $0.03 and revenue of $96.78 million exceeding forecasts. The company maintained a high shuttle tanker fleet utilization rate of 96.8%, contributing to an operating income of $15.6 million and Adjusted EBITDA of $57.6 million. It also expanded its fleet by acquiring the Hedda Knutsen and declared a cash distribution of $0.075 per common unit, supported by robust liquidity of $143.3 million. These results highlight KNOT's operational efficiency and strategic growth in the niche crude oil transport sector.
Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...
Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...
Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...
